FDA Inspection 1060984 — Aamir Z. Jamal, MD

Aamir Z. Jamal, MD — FEI 3006019672

The FDA completed an inspection of Aamir Z. Jamal, MD on July 20, 2018 in San Dimas, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 20, 2018
Fiscal Year
2018
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
San Dimas, CA (United States)

Additional Details

Clinical Investigator (CI)